FDA
6 results

Addressing Inconsistent Label Claims in the Hemp and Cannabis Industry

Infused products on the cannabis market frequently test lower in cannabinoids than advertised. CV Sciences and SC Labs weigh in on how rigorous testing can address inconsistencies.

This Policy Wonk Is Changing the Conversation About Cannabis on Capitol Hill

Over the past six months, John Hudak has quietly become one of the most influential voices on national cannabis policy in the U.S.

How GW Pharma Could Use U.S. Patents to Shape the Future of Medical Cannabis

After its success with epilepsy drug Epidiolex, the British company is patenting drugs to treat cancer, epilepsy, diabetes — even constipation.

The Shake: An Eric Holder Facepalm, Vermont’s Speedy Progress, and Cannabis Ceviche

Vermont is making quick progress toward being the country's next legal state. Eric Holder saves his call to reschedule for when he's impotent to change anything. And can Connecticut get some cannabis revenue already?

The Shake: Roseanne Gets in the Biz, Chris & Carly Get Out

A new Senate bill expected Thursday afternoon would also give students with drug convictions a chance at federal student aid.

Studies on Cannabis Vastly Outnumber Most FDA-Approved Pharmaceuticals

More clinical studies have been performed on cannabis than most legal medications approved by the FDA.